AbbVie Says “V” Is For V-Shaped Recovery

Q2 Victories Include Botox Rebound, Big Skyrizi, Rinvoq Gains

The firm’s major product revenues bounced back from the pandemic-troubled second quarter, with Botox recovering as predicted.

Money Wave
AbbVie rebounded solidly in Q3 from its pandemic-related issues in Q2

More from Earnings

More from Business